Interestingly, the studies were undertaken to understand the RAs and their derivatives unveil their potential to target stemness maintenance transcription machinery (NANOG, SOX2 and OCT3/4)-dependent lineage transformation of neuroblastoma cells, in addition to their established tumor regression and tumor cell differentiation effects. The gene discussed is NANOG; the disease is neoplasm.